B''lgarska kardiologiia最新文献_第6页

Overview of the catheter-based methods for treatment of mitralregurgitation 基于导管的三尖瓣反流治疗方法综述

B''lgarska kardiologiia Pub Date : 2022-06-20 DOI: 10.3897/bgcardio.28.e82154

I. Petrov, A. Cherneva, S. Vasilev, Y. Gecov, Z. Stankov

{"title":"Overview of the catheter-based methods for treatment of mitralregurgitation","authors":"I. Petrov, A. Cherneva, S. Vasilev, Y. Gecov, Z. Stankov","doi":"10.3897/bgcardio.28.e82154","DOIUrl":"https://doi.org/10.3897/bgcardio.28.e82154","url":null,"abstract":"Mitral regurgitation or mitral insuffi ciency is the second most common valve pathology requiring a surgical treatment worldwide. It is characterized by an abnormal return of blood from the left ventricle to the left atrium during the systole. The incidence of mitral regurgitation increases in line with the rise in the life expectancy and the overall aging of the world population. According to the pathoanatomy and the mechanism of development, there are two main types of mitral regurgitation: a primary (degenerative) regurgitation and secondary (functional) regurgitation. In the fi rst type, there is organic damage to the valve and/or the valve apparatus, and in the second type, there is a secondary dysfunction of the mitral valve due to damage to the structure and/or the function of the left ventricle. The treatment of choice for the management of the mitral regurgitation is a surgical intervention. In recent years new high-tech transcatheter methods of treatment have been introduced in clinical practice. The most popular and proven method of treatment in patients who could not undergo classic cardiac surgery is the MitraClip edge-to-edge transcatheter approximation system. Other endovascular methods of treatment are percutaneous plasty device Pascal (Edwards Lifesciences) and Cardioband using transseptal approach, and also NeoChord and Harpoon using transapical approach.","PeriodicalId":33976,"journal":{"name":"B''lgarska kardiologiia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49330618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical case of endovascular coronary revascularization after TAVI TAVI后血管内冠状动脉血运重建的临床病例

B''lgarska kardiologiia Pub Date : 2022-06-20 DOI: 10.3897/bgcardio.28.e82140

P. Polomski, Z. Stankov, I. Petrov, Z. Stoykova

引用次数: 0

Balloon expandable vs. self-expandable transcatheter aortic valve prosthesis short-term results of retrospective study 球囊可膨胀与自膨胀经导管主动脉瓣假体近期回顾性研究结果

B''lgarska kardiologiia Pub Date : 2022-06-20 DOI: 10.3897/bgcardio.28.e83164

H. Angelov, P. Simeonov, P. Krastev, F. Abedinov, J. Jorgova, D. Trendafilova

{"title":"Balloon expandable vs. self-expandable transcatheter aortic valve prosthesis short-term results of retrospective study","authors":"H. Angelov, P. Simeonov, P. Krastev, F. Abedinov, J. Jorgova, D. Trendafilova","doi":"10.3897/bgcardio.28.e83164","DOIUrl":"https://doi.org/10.3897/bgcardio.28.e83164","url":null,"abstract":"Transcutaneous aortic valve implantation has been established as an effective method for the treatment of highgrade aortic stenosis in non-operative, high-risk for conventional surgery patients. According to the developed implantation technologies, the prostheses are divided into balloon-expandable valve prostheses (balloon-expandable valves, BEV) and self-expanding valve prostheses (self-expanding prostheses SEV). The two types of devices have different models for implantation, stratum architecture, cusps characteristics, leading to different hemodynamics, frequency of use and performance of normal prosthesis function. The research aims to monitor the short-term results, up to 1 month after discharge, in terms of mortality, the manifestation of heart failure, (para) prosthetic regurgitation, implantation of a pacemaker, and vascular complications. Materials and methods: the article presents a retrospective follow-up of a total of 230 high-risk for conventional cardiac surgery patients with high-grade aortic stenosis treated in a cardiology clinic at UMHAT St. Ekaterina Sofia until 2020, divided into two groups depending on the implanted type of prosthesis. Conclusions: The results obtained based on our experience prove the safety of new prostheses. When choosing between BEV and SEV, the best clinical outcome requires a good knowledge of the strengths and weaknesses of using medical devices with a personalized approach consistent with the clinical and anatomical characteristics of the patient.","PeriodicalId":33976,"journal":{"name":"B''lgarska kardiologiia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48815583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Balloon aortic valvuloplasty in degenerative aortic stenosis 球囊主动脉瓣成形术治疗退行性主动脉狭窄

B''lgarska kardiologiia Pub Date : 2022-06-20 DOI: 10.3897/bgcardio.28.e82135

P. Polomski, Z. Stankov, I. Petrov, I. Tasheva, G. Dobrev

引用次数: 0

Safety and efficiency of the minimalistic and precise approachfor transcatheter aortic valve implantation (TAVI) comparedto the standard one 经导管主动脉瓣置入术的微创精准入路与标准入路的安全性和有效性比较

B''lgarska kardiologiia Pub Date : 2022-06-20 DOI: 10.3897/bgcardio.28.e82274

I. Petrov, Z. Stankov, P. Polomski, J. Stoykova, A. Cherneva, D. Boychev, M. Bonev

{"title":"Safety and efficiency of the minimalistic and precise approachfor transcatheter aortic valve implantation (TAVI) comparedto the standard one","authors":"I. Petrov, Z. Stankov, P. Polomski, J. Stoykova, A. Cherneva, D. Boychev, M. Bonev","doi":"10.3897/bgcardio.28.e82274","DOIUrl":"https://doi.org/10.3897/bgcardio.28.e82274","url":null,"abstract":"Since the first procedure in humans in 2002, transcatheter aortic valve implantation (TAVI) has evolved from innovative procedure of the future to treatment of choice in high-risk patients with potential to become a routine procedure in the near future. Thanks to the excellent safety profile, the emerging evidence from clinical trials, TAVI has raised its class of recommendation in the guidelines. The constantly upraising frequency of TAVI and the experience gained have led to the need of procedure improvement and standardization. Between 2013 and 2021 208 patients underwent TAVI in our cardiovascular center. The standard approach was used for 141 of them and the minimalistic and precise approach for the rest 67 patients. The main focus of this manuscript is improvement of the procedure results, quality of life and comfort of the patients, while providing a better pharmacoeconomic profile.The minimalistic and precise protocol of implantation and the vascular device closure are thoroughly described. The safety and the efficiency of the minimalistic and precise approach compared to the standard one, which is considered the ”gold standard” are proven. At the same time the minimalistic approach is described as superior to the standard one in using the radial artery as second vascular approach to reduce vascular complications and bleeding. Other advantage of the minimalistic approach is the implantation of the transcatheter aortic valve in position 0/1 while using rapid pacing, to reduce the frequency of pacemaker implantation, reduction of paravalvular leak and reduction of hospital stay. TAVI has proved to be an alternative to surgical aortic valve replacement in high risk patients and in the past years also in intermediate and low risk patients. In order TAVI to become a PCI-like procedure it must be simplified. That is exactly why the minimalistic and precise approach for TAVI is needed and it is the future of the procedure.","PeriodicalId":33976,"journal":{"name":"B''lgarska kardiologiia","volume":"66 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70395798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Transcatheter aortic valve implantation via transaortic surgical access 经导管主动脉瓣植入术经主动脉手术通路

B''lgarska kardiologiia Pub Date : 2022-06-20 DOI: 10.3897/bgcardio.28.e83660

A. Popova, D. Trendafilova, J. Jorgova, D. Petkov, F. Abedinov, T. Hristova, Stanislav Ivanov

引用次数: 0

Magnetic resonance imaging of MINOCA in underlying non-ischemic dilated cardiomyopathy: a case report 非缺血性扩张型心肌病MINOCA磁共振成像1例

B''lgarska kardiologiia Pub Date : 2022-06-20 DOI: 10.3897/bgcardio.28.e79582

H. Baychev, E. Kostadinova, A. Partenova, K. Genova, T. Shalganov

引用次数: 0

TAVI in bicuspid aortic valve 二尖瓣主动脉瓣TAVI

B''lgarska kardiologiia Pub Date : 2022-06-20 DOI: 10.3897/bgcardio.28.e82418

I. Dimitrova, J. Jorgova, P. Simeonov, H. Angelov, D. Trendafilova

引用次数: 0

Еditorial 社论

B''lgarska kardiologiia Pub Date : 2022-06-20 DOI: 10.3897/bgcardio.28.e84919

D. Trendafilova-Lazarova

引用次数: 0

Therapeutic options in the treatment of infectious endocarditis of an implantable cardiac device lead 植入式心脏装置致感染性心内膜炎的治疗选择

B''lgarska kardiologiia Pub Date : 2022-06-20 DOI: 10.3897/bgcardio.28.e81189

M. Ivanov, M. Peneva, I. Ivanov, N. Gotcheva, L. Boyadzhiev

{"title":"Therapeutic options in the treatment of infectious endocarditis of an implantable cardiac device lead","authors":"M. Ivanov, M. Peneva, I. Ivanov, N. Gotcheva, L. Boyadzhiev","doi":"10.3897/bgcardio.28.e81189","DOIUrl":"https://doi.org/10.3897/bgcardio.28.e81189","url":null,"abstract":"Right-sided endocarditis, and endocarditis of the tricuspid valve in particular, is a relatively uncommon condition, encountered in approximately 5 to 10 percent of all cases of infectious endocarditis (IE). The recent increase in the prevalence of right-sided IE is attributed to intravenous drug abuse as well as the increased utilization of implantable cardiac devices such as pacemakers, implantable cardioverter-defi brillators, and cardiac resynchronization therapy devices. These cases pose signifi cant therapeutic challenges, especially when right-sided devices are involved. We present a case of 45-year-old male patient with proven IE with involvement of the tricuspid valve and implantable cardiac device lead and demonstrate the results of an antibacterial treatment and surgical interventions carried out in two steps – explanation of the lead of the implantable cardiac device, excision of the tricuspid valve, and implantation of an epicardial implantable device; subsequent tricuspid valve replacement with mechanical valve, surgical revascularization, and fi nally replacement of the thrombosed mechanical valve with a biological valve. The optimal preoperative management and the following comprehensive surgical intervention resulted in resolution of IE as it has been demonstrated by the lack of recurrence of systemic infl ammatory response syndrome and no further hospitalisations due to cardiovascular events.","PeriodicalId":33976,"journal":{"name":"B''lgarska kardiologiia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42258742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0